“The maximum co-pay assistance available annually is $20,000 ($40,000 for hereditary angioedema treatment, $10,000 for cytomegalovirus).”
From the maker’s offer on takedapatientsupport.com, checked November 17, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Authorized generic
One was sold before, but not anymore.
Not soldNo longer sold
Regular generic
Same active ingredient as Firazyr. Fillers and dyes can differ.
Cash priceAsk the pharmacyUsually the lowest
Who makes it
Makers and their savings cards
7 companies sell a generic of Firazyr that the FDA rates a substitute. A pharmacy fills whichever one it stocks. 2 of them have their own savings cards, listed first. Each works only with that maker’s version. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.
It’s mostly filled by specialty pharmacies. Your prescriber’s office or insurer can tell you which one to use.
“If you have private or commercial prescription insurance, you may be eligible to receive Icatibant Inj Pre-Filled Syringe for as little as $0 per month, subject to monthly and annual limits.”
How it looks, what’s in it, NDCs
30 mg/3 mL
Package
NDC
Carton of 3 mL
69097-664-34
Carton of 9 mL
69097-664-68
Inactive ingredients: acetic acid, sodium chloride, sodium hydroxide, water
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site, checked November 17, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
FIRAZYR is a bradykinin B2 receptor antagonist indicated for treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
Source: the FDA label for Firazyr (Takeda Pharmaceuticals America, Inc.), July 7, 2025. Full label on DailyMed
Prices checked November 17, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/firazyr/